Brief UV exposure is often coordinated
By Edward Fish, Senior Vice President and General Manager of Varietal Solutions at Bay State Milling Key takeaways: GLP-1 medications are reshaping consumer food behavior , with users seeking smaller, more nutrient-dense portions that support satiety, digestion, and overall wellness driving a $190 billion market shift
While GLP-1 medications can be highly effective for sustainable weight loss , maintaining results after stopping treatment often depends on the habits, metabolic health, and support systems built during the process
25K Americans starting Wegovy weekly as supply increases and prices drop, drugmaker says Novo Nordisk reported that net pricing will be lower in the US At least 25,000 Americans are beginning treatment with Novo Nordisk's Wegovy each week and that figure is growing, the company said
While the market reaction has been strong, a closer look at the data provides a necessary reality check
These results represent genuine body composition changes rather than temporary fluctuations
